High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus

被引：52

作者：

Sookoian, S

Neglia, V

Castaño, G

Frider, B

Kien, MC

Chohuela, E

机构：

来源：

ARCHIVES OF DERMATOLOGY | 1999年 / 135卷 / 08期

关键词：

D O I：

10.1001/archderm.135.8.1000

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：1000 / 1001

页数：2

共 4 条

[1]

LEDINGHEN V, 1997, GASTROENTEROL CLIN B, V21, P523

[2] PHARMACOKINETICS AND LONG-TERM TOLERANCE TO RIBAVIRIN IN ASYMPTOMATIC PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].

LERTORA, JJL ;

REGE, AB ;

LACOUR, JT ;

FERENCZ, N ;

GEORGE, WJ ;

VANDYKE, RB ;

AGRAWAL, KC ;

HYSLOP, NE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (04) :442-449

[3] Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C [J].

Reichard, O ;

Norkrans, G ;

Frydén, A ;

Braconier, JH ;

Sönnerborg, A ;

Weiland, O .

LANCET, 1998, 351 (9096) :83-87

[4] Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C - Meta-analysis of individual patient data from European centers [J].

Schalm, SW ;

Hansen, BE ;

Chemello, L ;

Bellobuono, A ;

Brouwer, JT ;

Weiland, O ;

Cavalletto, L ;

Schvarcz, R ;

Ideo, G ;

Alberti, A .

JOURNAL OF HEPATOLOGY, 1997, 26 (05) :961-966

← 1 →